{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T01:32:30Z","timestamp":1777858350369,"version":"3.51.4"},"reference-count":22,"publisher":"SAGE Publications","issue":"1","license":[{"start":{"date-parts":[[1994,1,1]],"date-time":"1994-01-01T00:00:00Z","timestamp":757382400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Psychopharmacol"],"published-print":{"date-parts":[[1994,1]]},"abstract":"<jats:p>\n                    RX336-M (7,8-dihydro-5',6'-dimethylcyclohex-5'-eno-1',2',8',14 codeinone) induced a complex of simultaneous rapid movements of body parts accompanied by a single squeak-vocalization, which occurred at irregular intervals, when injected i.p. in mice. The complex included whole body jerks and head-shakes and its frequency was dose dependent between 0.1 and 20 mg\/kg. Frequency after a 5 mg\/kg dose was reduced by haloperidol (0.5-10 mg\/kg, i.p.), ritanserin (0.1-10 mg\/kg, i.p.) and ICI 169,369 (2.0 mg\/kg, i.p.), suggesting the possible involvement of 5-HT\n                    <jats:sub>2A<\/jats:sub>\n                    and\/or dopamine receptors. The possible relevance of the behavioural effects of RX336-M to the tics and vocalization of Tourette's syndrome is discussed.\n                  <\/jats:p>","DOI":"10.1177\/026988119400800105","type":"journal-article","created":{"date-parts":[[2007,3,17]],"date-time":"2007-03-17T23:45:17Z","timestamp":1174175117000},"page":"27-31","source":"Crossref","is-referenced-by-count":4,"title":["Complex of rapid movements and vocalization induced by RX336-M in mice: possible relevance to Tourette's syndrome"],"prefix":"10.1177","volume":"8","author":[{"given":"Serdar M.","family":"Dursun","sequence":"first","affiliation":[{"name":"Pharmaceutical Sciences Institute, Aston University, Birmingham B4 7ET, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sheila L.","family":"Handley","sequence":"additional","affiliation":[{"name":"Pharmaceutical Sciences Institute, Aston University, Birmingham B4 7ET, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"179","published-online":{"date-parts":[[1994,1,1]]},"reference":[{"key":"atypb1","volume-title":"Diagnostic and Statistical Manual of Mental Disorders","author":"American Psychiatric Association","year":"1987","edition":"3"},{"key":"atypb2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0773.1984.tb01996.x"},{"key":"atypb3","doi-asserted-by":"publisher","DOI":"10.1016\/0014-2999(88)90005-2"},{"key":"atypb4","first-page":"1497","volume":"40","author":"Cowan A.","year":"1981","journal-title":"Fed Proc"},{"key":"atypb5","doi-asserted-by":"publisher","DOI":"10.1007\/BF00421140"},{"key":"atypb6","doi-asserted-by":"publisher","DOI":"10.1007\/BF00426956"},{"key":"atypb7","first-page":"225P","volume":"105","author":"Dursun S.M.","year":"1992","journal-title":"Br J Pharmacol"},{"key":"atypb8","doi-asserted-by":"publisher","DOI":"10.1111\/j.1476-5381.1989.tb11858.x"},{"key":"atypb9","doi-asserted-by":"publisher","DOI":"10.1016\/0091-3057(82)90047-8"},{"key":"atypb10","doi-asserted-by":"publisher","DOI":"10.1016\/0014-2999(83)90584-8"},{"key":"atypb11","unstructured":"Green A.R., Heal D.J. (1985) The effects of drugs on serotonin-mediated behavioural models. In Green A R (ed.), Neuropharmacology of serotonin. Oxford University Press , Oxford, pp. 326-365"},{"key":"atypb12","doi-asserted-by":"publisher","DOI":"10.1016\/0028-3908(83)90147-8"},{"key":"atypb13","first-page":"235","volume":"85","author":"Handley S.L.","year":"1992","journal-title":"Adv Biosci"},{"key":"atypb14","doi-asserted-by":"publisher","DOI":"10.1016\/0165-6147(86)90371-8"},{"key":"atypb15","doi-asserted-by":"publisher","DOI":"10.1016\/0165-6147(93)90016-D"},{"key":"atypb16","doi-asserted-by":"publisher","DOI":"10.1111\/j.1476-5381.1991.tb12369.x"},{"key":"atypb17","first-page":"600","volume":"27","author":"Leysen J.E.","year":"1985","journal-title":"Mol Pharmacol"},{"key":"atypb18","first-page":"238","volume":"251","author":"Meltzer H.Y.","year":"1989","journal-title":"J Pharmacol Exp Ther"},{"key":"atypb19","doi-asserted-by":"publisher","DOI":"10.1016\/0028-3908(90)90112-5"},{"key":"atypb20","doi-asserted-by":"publisher","DOI":"10.1016\/0024-3205(76)90212-5"},{"key":"atypb21","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.154.2.147"},{"key":"atypb22","doi-asserted-by":"publisher","DOI":"10.1016\/0014-2999(83)90297-2"}],"container-title":["Journal of Psychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/026988119400800105","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/026988119400800105","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T00:11:42Z","timestamp":1777507902000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/026988119400800105"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1994,1]]},"references-count":22,"journal-issue":{"issue":"1","published-print":{"date-parts":[[1994,1]]}},"alternative-id":["10.1177\/026988119400800105"],"URL":"https:\/\/doi.org\/10.1177\/026988119400800105","relation":{},"ISSN":["0269-8811","1461-7285"],"issn-type":[{"value":"0269-8811","type":"print"},{"value":"1461-7285","type":"electronic"}],"subject":[],"published":{"date-parts":[[1994,1]]}}}